Carolina Martinez Grijalva

Carolina Martinez Grijalva

Auto-generated profile, based on publicly available information

Carolina Martinez Grijalva

Institute of Human Genetics University Medical Center Göttingen Göttingen Germany

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2022 in Clinical Genetics
Verified
Journal Article
Open access
IGIpek Ilgin Gönenc
Ipek Ilgin Gönenc
NENursel H. Elcioglu
Nursel H. Elcioglu
CGCarolina Martinez Grijalva
Carolina Martinez Grijalva
SASeda Aras
Seda Aras
NGNadine Großmann
Nadine Großmann
BWBernd Wollnik
Bernd Wollnik
Bloom syndrome (BS) is an autosomal recessive disorder with characteristic clinical features of primary microcephaly, growth deficiency, cancer predisposition, and immunodeficiency. Here, we report the clinical and molecular findings of eight patients from six families diagnosed with BS. We identified causative pathogenic variants in all families including three different variants in BLM and one variant in RMI1. The homozygous c.581_582delTT;p.Phe194* and c.3164G>C;p.Cys1055Ser variants in BLM have already been reported in BS patients, while the c.572_573delGA;p.Arg191Lysfs*4 variant is novel. Additionally, we present the detailed clinical characteristics of two cases with BS in which we previously identified the biallelic loss‐of‐function variant c.1255_1259delAAGAA;p.Lys419Leufs*5 in RMI1. All BS patients had primary microcephaly, intrauterine growth delay, and short stature, presenting the phenotypic hallmarks of BS. However, skin lesions and upper airway infections were observed only in some of the patients. Overall, patients with pathogenic BLM variants had a more severe BS phenotype compared to patients carrying the pathogenic variants in RMI1, especially in terms of immunodeficiency, which should be considered as one of the most important phenotypic characteristics of BS.

1 October 2021 in European Journal of Medical Genetics
Verified
Journal Article
Closed access
KKKatharina Khuller
Katharina Khuller
GYGökhan Yigit
Gökhan Yigit
CGCarolina Martínez Grijalva
Carolina Martínez Grijalva
JAJanine Altmüller
Janine Altmüller
HTHolger Thiele
Holger Thiele
AKAlma Kuechler
Alma Kuechler

10 November 2021 in medRxiv
Verified
Preprint
Open access
PDF file
IGIpek Ilgin Gönenc
Ipek Ilgin Gönenc
NENursel Elcioglu
Nursel Elcioglu
CGCarolina Martinez Grijalva
Carolina Martinez Grijalva
SASeda Aras
Seda Aras
NGNadine Großmann
Nadine Großmann
BWBernd Wollnik
Bernd Wollnik
Bloom syndrome (BS) is an autosomal recessive disease with characteristic clinical features of primary microcephaly, growth deficiency, skin lesions, cancer predisposition, and immunodeficiency. Here, we report the clinical and molecular findings of eight patients from six families diagnosed with BS. We identified causative mutations in all families, three different homozygous mutations in BLM and one causative homozygous mutation in RMI1 . The homozygous c.581_582delTT (p.Phe194*) and c.3164G>C (p.Cys1055Ser) mutations in BLM have already been reported in BS patients, while the c.572_573delGA (p.Arg191Lysfs*4) is novel. Interestingly, whole-exome sequencing revealed a homozygous loss-of-function mutation in RMI1 in two BS patients of a consanguineous Turkish family. All BS patients had primary microcephaly, intrauterine growth delay, and short stature, presenting the phenotypic hallmarks of BS. However, a narrow face, skin lesions, and upper airway infections were observed only in some of the patients. Overall, patients with homozygous BLM mutations had a more severe BS phenotype compared to patients carrying the homozygous RMI1 mutation, especially in terms of immunodeficiency and associated recurrent infections. Low-level immunoglobulins were observed in all BLM -mutated patients, emphasizing the immunodeficiency profile of the disease, which should be considered as an important phenotypic characteristic of BS, especially in the current Covid-19 pandemic era.